OncLive/ SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer January 15th 2024January 15th 2024 Read More
PRESS RELEASE: Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio October 4th 2023 Read More
Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection May 16th 2023 Read More
CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in Boston March 7th 2022November 4th 2021 Read More
Team Shorla Oncology complete 100k in 30 days for Breast Cancer March 7th 2022June 30th 2021 Read More
FDA filing acceptance and priority review received for SH-111 March 7th 2022April 23rd 2021 Read More
Shorla Oncology named Local Enterprise of the Year at The Irish Times Business Awards 2020 March 7th 2022September 3rd 2020 Read More